Scarica l'app Stockscreener
0.8248
2.75%
-0.0233
Dopo l'orario di chiusura:
.86
0.0352
+4.27%
Precedente Chiudi:
$0.8481
Aprire:
$0.87
Volume 24 ore:
317.50K
Relative Volume:
0.73
Capitalizzazione di mercato:
$16.13M
Reddito:
$411.00K
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-1.8745
EPS:
-0.44
Flusso di cassa netto:
$-4.88M
1 W Prestazione:
-7.48%
1M Prestazione:
-43.51%
6M Prestazione:
-41.09%
1 anno Prestazione:
-71.26%
Intervallo 1D:
$0.81
$0.87
Intervallo di 1 settimana:
$0.81
$0.9246
Portata 52W:
$0.7749
$3.05
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Nome
Lexaria Bioscience Corp
Settore
Industria
Telefono
250-765-6424
Indirizzo
100 - 740 MCCURDY ROAD, KELOWNA
Confronta LEXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.8248 | 19.43M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lexaria Bioscience Corp Borsa (LEXX) Ultime notizie
How to use a screener to detect Lexaria Bioscience Corp. Equity Warrant breakouts2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
Is Lexaria Bioscience Corp. stock bottoming outProfit Target & Stepwise Entry/Exit Trade Alerts - newser.com
How Lexaria Bioscience Corp. stock performs in rising dollar environment2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com
What catalysts could drive Lexaria Bioscience Corp. stock higherMarket Risk Analysis & Long-Term Safe Investment Plans - newser.com
Analyzing net buyer seller activity in Lexaria Bioscience Corp.July 2025 Summary & Fast Momentum Entry Tips - newser.com
Lexaria Bioscience files to sell 2.76M shares of common stock for holders - MSN
Technical signs of recovery in Lexaria Bioscience Corp. Equity WarrantTrade Analysis Report & Verified Swing Trading Watchlist - newser.com
Chart based exit strategy for Lexaria Bioscience Corp.2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
Combining machine learning predictions for Lexaria Bioscience Corp. Equity WarrantQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Can trapped investors hope for a rebound in Lexaria Bioscience Corp. Equity WarrantQuarterly Portfolio Review & High Return Trade Guides - newser.com
Is Lexaria Bioscience Corp. stock ready for a breakoutJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
Price action breakdown for Lexaria Bioscience Corp. Equity WarrantCEO Change & Daily Stock Trend Reports - newser.com
Is Lexaria Bioscience Corp. Equity Warrant stock in correction or buying zone2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Will Lexaria Bioscience Corp. Equity Warrant outperform the marketTrade Risk Summary & Technical Buy Zone Confirmations - newser.com
Earnings visualization tools for Lexaria Bioscience Corp. Equity Warrant2025 Valuation Update & Safe Capital Growth Tips - newser.com
Can Lexaria Bioscience Corp. hit a new high this monthMarket Risk Analysis & Smart Allocation Stock Reports - newser.com
Lexaria expands pharmaceutical outreach with new advisory firm By Investing.com - Investing.com Nigeria
Lexaria Bioscience Corp. Provides Strategic Update - NewMediaWire
Lexaria Bioscience Expands Strategic Outreach and Secures New Patents - TipRanks
Lexaria (LEXX) Expands R&D Efforts with Enhanced Funding and New Partnerships - GuruFocus
Lexaria expands pharmaceutical outreach with new advisory firm - Investing.com India
$4.0M Financing backs Lexaria's global BD push; 4 new patents bolster DehydraTECH R&D into 2026 - Stock Titan
Can trapped investors hope for a rebound in Lexaria Bioscience Corp.2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Historical volatility pattern of Lexaria Bioscience Corp. visualized2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Custom watchlist performance reports with Lexaria Bioscience Corp.2025 Major Catalysts & Pattern Based Trade Signal System - newser.com
News impact scoring models applied to Lexaria Bioscience Corp. Equity WarrantMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Can swing trading help recover from Lexaria Bioscience Corp. Equity Warrant losses2025 Key Lessons & Weekly Top Gainers Alerts - newser.com
Lexaria Bioscience Corp Stock Analysis and ForecastAutomated Trading Signals & Explosive Capital Growth - earlytimes.in
Will Lexaria Bioscience Corp. see short term momentumMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com
Lexaria Bioscience Corp. Equity Warrant stock daily chart insightsWeekly Risk Report & High Conviction Trade Alerts - newser.com
Real time social sentiment graph for Lexaria Bioscience Corp.Quarterly Trade Review & Technical Pattern Based Buy Signals - newser.com
Smart tools for monitoring Lexaria Bioscience Corp.’s price actionWeekly Market Outlook & Weekly Stock Performance Updates - newser.com
Can Lexaria Bioscience Corp. Equity Warrant stock deliver surprise earnings beatCPI Data & Fast Moving Trade Plans - newser.com
When is the best time to exit Lexaria Bioscience Corp.Entry Point & Community Verified Trade Signals - newser.com
Is Lexaria Bioscience Corp. stock reversal real or fakeAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
What drives Lexaria Bioscience Corp stock priceFundamental Stock Analysis & High Yield Trading Plans - earlytimes.in
Lexaria Bioscience Corp. Equity Warrant stock trendline breakdownWeekly Stock Summary & Accurate Buy Signal Alerts - newser.com
What’s next for Lexaria Bioscience Corp. Equity Warrant stock price2025 Price Action Summary & Breakout Confirmation Alerts - newser.com
Lexaria Bioscience Corp Azioni (LEXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lexaria Bioscience Corp Azioni (LEXX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BUNKA CHRISTOPHER | Director |
Jul 30 '25 |
Buy |
0.91 |
11,900 |
10,866 |
281,912 |
| McKechnie William Edward | Director |
Jul 29 '25 |
Buy |
0.91 |
5,000 |
4,532 |
18,191 |
| DOCHERTY JOHN MARTIN | President & CSO |
Jul 29 '25 |
Buy |
0.93 |
5,376 |
4,989 |
5,376 |
| Carle Vanessa | Secretary |
Jul 29 '25 |
Buy |
0.91 |
750 |
682 |
750 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Jul 29 '25 |
Buy |
0.91 |
15,000 |
13,641 |
65,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 03 '24 |
Buy |
2.47 |
27,172 |
67,175 |
50,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 02 '24 |
Buy |
2.24 |
22,828 |
51,217 |
22,828 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):